Search

Pharmagest Interactive

Fechado

0

Visão Geral

Variação de preço das ações

24h

Atual

Mín

Máximo

Indicadores-chave

By Trading Economics

Rendimento

17M

Vendas

116M

P/E

Médio do Setor

15.774

Rendimento de Dividendos

3.41

Margem de lucro

14.879

Funcionários

1,400

EBITDA

116M

Dividendos

By Dow Jones

Rendimento de Dividendos

Médio do Setor

3.41%

Próximos Ganhos

30 de mar. de 2026

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

567M

Abertura anterior

0

Fecho anterior

0

Pharmagest Interactive Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

15 de mar. de 2026, 21:14 UTC

Notícias Principais

Week Ahead for FX, Bonds: Central Bank Decisions -2-

15 de mar. de 2026, 21:14 UTC

Notícias Principais

Week Ahead for FX, Bonds: Central Bank Decisions in Focus After Jump in Energy Prices

16 de mar. de 2026, 00:00 UTC

Notícias Principais

Hack on U.S. Medical Company Shows Reach of Iran's Cyber Capabilities -- WSJ

15 de mar. de 2026, 23:45 UTC

Conversa de Mercado

Nikkei May Decline on Concerns About Prolonged Middle East Conflict -- Market Talk

15 de mar. de 2026, 23:44 UTC

Conversa de Mercado
Notícias Principais

Gold Falls as Rising Energy Prices Exacerbate Inflation Worries -- Market Talk

15 de mar. de 2026, 23:35 UTC

Conversa de Mercado
Notícias Principais

Oil Futures Rise on Supply Disruption Concerns -- Market Talk

15 de mar. de 2026, 23:00 UTC

Aquisições, Fusões, Aquisições de Empresas

Micron Completes Acquisition Of PSMC's Tongluo P5 Site In Taiwan >MU

15 de mar. de 2026, 22:37 UTC

Conversa de Mercado

March Rate Hike Would Distance RBA From Government's May Budget -- Market Talk

15 de mar. de 2026, 22:18 UTC

Conversa de Mercado

RBA's Likely Hike Motivated By Inflation, Not Middle East -- Market Talk

15 de mar. de 2026, 22:14 UTC

Ganhos

Genscript Biotech 2025 Adj Net $230.35M Vs. Adj Net $59.83M>1548.HK

15 de mar. de 2026, 22:14 UTC

Ganhos

Genscript Biotech: 2025 Loss Due to High Base Effect, One-off Unrealized Gains Seen Last Year >1548.HK

15 de mar. de 2026, 22:14 UTC

Ganhos

Genscript Biotech 2025 Rev $959.53M Vs. $594.49M >1548.HK

15 de mar. de 2026, 22:14 UTC

Ganhos

Genscript Biotech 2025 Loss $532.83M Vs. Net $2.96B >1548.HK

15 de mar. de 2026, 22:14 UTC

Ganhos

Genscript Biotech: 2025 Rev Supported by Substantial Increase in License Revenue>1548.HK

15 de mar. de 2026, 22:00 UTC

Notícias Principais

Oil Industry Warns Trump Administration Energy Crisis Will Likely Worsen -- WSJ

15 de mar. de 2026, 22:00 UTC

Notícias Principais

Oil Industry Warns Trump Administration Energy Crisis Will Likely Worsen -- WSJ

15 de mar. de 2026, 03:00 UTC

Notícias Principais

For Xi, Iran War Reinforces View of U.S. as Dangerous Superpower -- WSJ

14 de mar. de 2026, 15:00 UTC

Notícias Principais

Iran War Delivers Windfall to America's Oil Country -- WSJ

14 de mar. de 2026, 02:03 UTC

Ganhos

This Copper Stock Is Worth Mining for Profits -- Barrons.com

14 de mar. de 2026, 01:32 UTC

Aquisições, Fusões, Aquisições de Empresas

Bill Ackman's Pershing Square IPO Is Back On -- Barrons.com

14 de mar. de 2026, 00:29 UTC

Aquisições, Fusões, Aquisições de Empresas

13D Filings -- Barrons.com

13 de mar. de 2026, 22:27 UTC

Conversa de Mercado
Notícias Principais

Bahrain Faces Uncertainty But Has Support Amid War, S&P Says -- Market Talk

13 de mar. de 2026, 22:13 UTC

Conversa de Mercado
Notícias Principais

Saudi Arabia Seen as Able to Weather Iran Conflict, S&P Says -- Market Talk

13 de mar. de 2026, 22:04 UTC

Conversa de Mercado
Notícias Principais

Emirate of RAK Outlook Stable Despite Iran War, S&P Says -- Market Talk

13 de mar. de 2026, 22:00 UTC

Aquisições, Fusões, Aquisições de Empresas

Trump Administration Set to Receive $10 Billion Fee for Brokering TikTok Deal -- WSJ

13 de mar. de 2026, 20:50 UTC

Conversa de Mercado

Health Care Roundup: Market Talk

13 de mar. de 2026, 20:50 UTC

Conversa de Mercado
Notícias Principais

Financial Services Roundup: Market Talk

13 de mar. de 2026, 20:02 UTC

Conversa de Mercado

Canada Rate Hike in 2026 Would Mark 'Extraordinarily Bad' Policy -- Market Talk

13 de mar. de 2026, 19:50 UTC

Conversa de Mercado
Notícias Principais

Oil Posts Weekly Gains As Middle East Conflict Drags On -- Market Talk

13 de mar. de 2026, 19:35 UTC

Notícias Principais

Oil Prices Hover Near $100. India Asks Iran to Allow 23 Tankers Through Strait of Hormuz. -- Barrons.com

Pharmagest Interactive Previsão

Consenso de Avaliação

By TipRanks

0 ratings

0

Comprar

0

Manter

0

Vender

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Pharmagest Interactive

Equasens Société anonyme provides healthcare IT solutions in Europe. The company develops electronic equipment, digital and robotic health, and equipment lease financing solutions. It also offers id., a pharmacy management software suite; id. PATIENT for the exchange of healthcare data; id. VENTE, which facilitates and secures prescription sales; id. COMMANDE, which manages orders and inventory; dispensing robots; Ségur id. services; FARMACLICK, a communication protocol; DIFARM, a modular solution for wholesalers-distributors; and PHARE, a retail management tool. In addition, the company offers patient medication adherence, patient loyalty, point-of-sale commercial performance, piloting pharmacy operations, pharmacy team training, securing pharmacy operations and health data, and digital communication solutions; and in-home nursing services and hospital-at-home, hospitals, and telemedicine solutions. Further, it provides id. DESK, an informative and interactive dashboard; id. UP!, a smartphone app; id. EASYQ, a queuing management solution; Miaterapia, a patient app; and MediStory for tracking patient records; ExpressVitale module; and MEDILINK, a health data hosting provider. Additionally, the company offers KAP&LINK2, a terminal with smart card and NFC reader; eS-KAP-Ad, a mobile device with a pre-loaded software; KAP-INSIDE, a mobile terminal; TI-KAP, which allows access to contact and contactless cards; AUTHENTIFICATEUR, a patented patient authentication system; KAP'TEUR by KAPELSE, a patented universal sensor; and NOVIAcare, which analyzes the behavior and activity of the elderly. It serves nursing homes, hospitals, in-house nursing care and hospital-at-home programs, regional health professional communities, multidisciplinary group practices, and individual healthcare professionals. The company was incorporated in 1996 and is headquartered in Villers-les-Nancy, France. Equasens Société anonyme is a subsidiary of Marque Verte Sante.
help-icon Live chat